X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare SUVEN LIFE with Lupin Ltd - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

SUVEN LIFE vs LUPIN LTD - Comparison Results

LUPIN LTD 
   Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    SUVEN LIFE LUPIN LTD SUVEN LIFE/
LUPIN LTD
 
P/E (TTM) x 16.2 16.6 97.9% View Chart
P/BV x 3.0 3.9 78.0% View Chart
Dividend Yield % 1.2 0.8 156.0%  

Financials

 SUVEN LIFE   LUPIN LTD
EQUITY SHARE DATA
    SUVEN LIFE
Mar-16
LUPIN LTD
Mar-16
SUVEN LIFE/
LUPIN LTD
5-Yr Chart
Click to enlarge
High Rs3392,127 15.9%   
Low Rs1441,294 11.2%   
Sales per share (Unadj.) Rs39.2304.1 12.9%  
Earnings per share (Unadj.) Rs7.550.4 14.8%  
Cash flow per share (Unadj.) Rs8.860.7 14.5%  
Dividends per share (Unadj.) Rs2.007.50 26.7%  
Dividend yield (eoy) %0.80.4 188.9%  
Book value per share (Unadj.) Rs49.0243.8 20.1%  
Shares outstanding (eoy) m127.28450.58 28.2%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x6.25.6 109.4%   
Avg P/E ratio x32.433.9 95.3%  
P/CF ratio (eoy) x27.528.2 97.6%  
Price / Book Value ratio x4.97.0 70.2%  
Dividend payout %26.814.9 180.1%   
Avg Mkt Cap Rs m30,732770,740 4.0%   
No. of employees `0001.016.4 5.8%   
Total wages/salary Rs m41621,077 2.0%   
Avg. sales/employee Rs Th5,236.18,379.6 62.5%   
Avg. wages/employee Rs Th436.51,289.0 33.9%   
Avg. net profit/employee Rs Th995.51,388.7 71.7%   
INCOME DATA
Net Sales Rs m4,995137,016 3.6%  
Other income Rs m1941,877 10.3%   
Total revenues Rs m5,189138,893 3.7%   
Gross profit Rs m1,23337,535 3.3%  
Depreciation Rs m1674,635 3.6%   
Interest Rs m54446 12.1%   
Profit before tax Rs m1,20534,330 3.5%   
Minority Interest Rs m0-88 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m25511,536 2.2%   
Profit after tax Rs m95022,707 4.2%  
Gross profit margin %24.727.4 90.1%  
Effective tax rate %21.233.6 63.0%   
Net profit margin %19.016.6 114.7%  
BALANCE SHEET DATA
Current assets Rs m4,98697,790 5.1%   
Current liabilities Rs m1,04253,872 1.9%   
Net working cap to sales %79.032.1 246.3%  
Current ratio x4.81.8 263.6%  
Inventory Days Days6185 72.0%  
Debtors Days Days39121 32.3%  
Net fixed assets Rs m3,12686,379 3.6%   
Share capital Rs m127901 14.1%   
"Free" reserves Rs m3,717105,735 3.5%   
Net worth Rs m6,236109,844 5.7%   
Long term debt Rs m43253,739 0.8%   
Total assets Rs m8,079224,378 3.6%  
Interest coverage x23.277.9 29.8%   
Debt to equity ratio x0.10.5 14.2%  
Sales to assets ratio x0.60.6 101.2%   
Return on assets %12.410.3 120.4%  
Return on equity %15.220.7 73.7%  
Return on capital %18.921.2 89.0%  
Exports to sales %87.549.1 178.3%   
Imports to sales %12.27.4 164.3%   
Exports (fob) Rs m4,37167,244 6.5%   
Imports (cif) Rs m61110,199 6.0%   
Fx inflow Rs m4,66671,405 6.5%   
Fx outflow Rs m94217,807 5.3%   
Net fx Rs m3,72453,598 6.9%   
CASH FLOW
From Operations Rs m922-3,690 -25.0%  
From Investments Rs m-619-69,434 0.9%  
From Financial Activity Rs m-69858,126 -1.2%  
Net Cashflow Rs m-396-14,998 2.6%  

Share Holding

Indian Promoters % 63.4 46.6 136.1%  
Foreign collaborators % 0.0 0.2 -  
Indian inst/Mut Fund % 0.0 11.3 -  
FIIs % 0.0 31.9 -  
ADR/GDR % 0.0 0.0 -  
Free float % 36.5 10.1 361.4%  
Shareholders   37,287 98,259 37.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare SUVEN LIFE With:   STERLING BIOTECH  PFIZER  ALEMBIC PHARMA  ORCHID PHARMA LTD  SANOFI INDIA  

Compare SUVEN LIFE With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Weak Finish to the Week Post Vishal Sikka's Exit as CEO of Infosys(Closing)

Share markets in India witnessed selling pressure, led by slump in shares of Infosys Ltd. after Vishal Sikka resigned as chief executive officer of the country's second-largest software services exporter.

Related Views on News

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Lupin: Decline in US Business Impacts Overall Growth (Quarterly Results Update - Detailed)

May 29, 2017

Currency fluctuation and one time provision impacts operating margins.

Lupin: US Business Drives Growth (Quarterly Results Update - Detailed)

Mar 8, 2017

Lupin has announced its 3QFY17 results. Net sales have grown by 31.5% YoY and net profits have surged by 20.7% YoY. Here is our analysis of the results.

Lupin: Key Products Drive US growth (Quarterly Results Update - Detailed)

Sep 12, 2016

Lupin has announced its 1QFY17results. Net sales have grown by 40% YoY and net profits have surged by 55.1% YoY. Here is our analysis of the results.

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

A 'Backdoor' to Multibaggers: It's Like Investing in Asian Paints Ten Years Ago(The 5 Minute Wrapup)

Aug 10, 2017

Don't miss these proxy bets on growing companies or in a few years you will be looking back with regret.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

SUVEN LIFE SHARE PRICE


Aug 18, 2017 (Close)

TRACK SUVEN LIFE

  • Track your investment in SUVEN LIFE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

SUVEN LIFE - MERCK LTD COMPARISON

COMPARE SUVEN LIFE WITH

MARKET STATS